Group items tagged

Adderall is a trading name for the combination drug that includes 4 types of amphetamine salts (Amphetamine aspartate, dextroamphetamine sulfate, dextroamphetamine saccharate, and amphetamine sulfate). In this, the two main ingredients Amphetamine and dextroamphetamine are the central nervous system stimulants that help to pay attention, stay focused, and control uncontrollable behavioral activities. Both Adderall vs Methylphenidate (commonly known as Ritalin) are stimulant medications prescribed for attention deficit hyperactivity disorder (ADHD). While they share the same goal of improving focus, attention, and reducing impulsivity, key differences exist in their composition, action, and side effects. Choosing the right one requires understanding these nuances and consulting a healthcare professional. Chemical Composition: Adderall: A brand name for a mixture of amphetamines (amphetamine and dextroamphetamine). These directly stimulate the central nervous system, increasing dopamine and norepinephrine levels. Methylphenidate: Not an amphetamine, but a psychostimulant that works by blocking the reuptake of dopamine and norepinephrine, essentially making them more available in the brain. Side Effects: Adderall: More likely to cause side effects like anxiety, insomnia, decreased appetite, headaches, and heart palpitations. Methylphenidate: More prone to causing side effects like nervousness, stomach upset, tics, and mood swings.

Laganside Crown Court, on Friday, sentenced Gerard Cullinan, a 48-year-old pharmacist and Director of Castlereagh Pharmacy Ltd in East Belfast, for unlawfully supplying controlled prescription medicines, including co-codamol and fentanyl, and for failing to maintain controlled drugs registers. Cullinan was sentenced to 11 months imprisonment, suspended for three years, and his pharmacy was fined £8,000. The sentencing follows an investigation by the Department of Health's Medicines Regulatory Group (MRG), which uncovered that Cullinan's pharmacy on Castlereagh Road had illegally supplied over 300,000 co-codamol tablets between January 2017 and June 2020. Additionally, the MRG investigation identified significant breaches in record-keeping for Class A controlled drugs such as fentanyl, tapentadol, methylphenidate, morphine, and oxycodone. "It is a serious criminal offence to sell or supply prescription only medicines without a prescription," said Peter Moore, Senior Medicines Enforcement Officer at the MRG, who led the investigation.

The Department of Health and Social Care (DHSC) and the Medicines and Healthcare Products Regulatory Agency (MHRA) have added five more medicines that cannot be hoarded or exported from the UK market. The government has taken the following action to address the "critical shortage" of attention deficit hyperactivity disorder (ADHD) drugs. In a crucial development on October 9, this strategic move aims to enable wholesalers to fulfil their legal obligation to supply these essential medicines to patients across the UK. The updated list of drugs incorporated "all" available strengths and pharmaceutical formulations, ensuring comprehensive coverage for patients' medical needs.